ES362475A1 - Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides. - Google Patents

Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides.

Info

Publication number
ES362475A1
ES362475A1 ES362475A ES362475A ES362475A1 ES 362475 A1 ES362475 A1 ES 362475A1 ES 362475 A ES362475 A ES 362475A ES 362475 A ES362475 A ES 362475A ES 362475 A1 ES362475 A1 ES 362475A1
Authority
ES
Spain
Prior art keywords
17alpha
alpha
preparation
steroids
trihydroxysteroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES362475A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM Delft BV
Original Assignee
Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Nederlandsche Gist en Spiritusfabriek BV filed Critical Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Publication of ES362475A1 publication Critical patent/ES362475A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21—LIGHTING
    • F21V—FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V17/00—Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages
    • F21V17/10—Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening
    • F21V17/20—Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening by toggle-action levers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES362475A 1968-01-23 1969-01-14 Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides. Expired ES362475A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB358768 1968-01-23

Publications (1)

Publication Number Publication Date
ES362475A1 true ES362475A1 (es) 1970-12-01

Family

ID=9761163

Family Applications (1)

Application Number Title Priority Date Filing Date
ES362475A Expired ES362475A1 (es) 1968-01-23 1969-01-14 Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides.

Country Status (12)

Country Link
US (1) US3557162A (US06534493-20030318-C00166.png)
AT (1) AT292929B (US06534493-20030318-C00166.png)
BE (1) BE726981A (US06534493-20030318-C00166.png)
CH (1) CH511822A (US06534493-20030318-C00166.png)
DE (1) DE1903118A1 (US06534493-20030318-C00166.png)
DK (1) DK120234B (US06534493-20030318-C00166.png)
ES (1) ES362475A1 (US06534493-20030318-C00166.png)
FR (2) FR8225M (US06534493-20030318-C00166.png)
GB (1) GB1227992A (US06534493-20030318-C00166.png)
IT (1) IT1036015B (US06534493-20030318-C00166.png)
NL (1) NL162083C (US06534493-20030318-C00166.png)
SE (1) SE339828B (US06534493-20030318-C00166.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033042B (it) * 1970-03-14 1979-07-10 Luso Farmaco Inst Desametazone 17 valerato e processi per la sua preparazione
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
DE3442527A1 (de) * 1983-11-23 1985-05-30 Bösha GmbH & Co KG, 4780 Lippstadt Langfeldleuchte fuer den einsatz in schlagwetter- und explosionsgeschuetzten bereichen
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
DK1775305T3 (en) 2000-08-05 2014-11-17 Glaxo Group Ltd 6.Alfa.,9.alfa.-difluoro-17.alfa.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alfa.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2039700A2 (en) * 2001-04-30 2009-03-25 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
UA116622C2 (uk) * 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Also Published As

Publication number Publication date
BE726981A (US06534493-20030318-C00166.png) 1969-07-16
FR8225M (US06534493-20030318-C00166.png) 1970-09-28
FR2000571A1 (US06534493-20030318-C00166.png) 1969-09-12
IT1036015B (it) 1979-10-30
CH511822A (de) 1971-08-31
NL6901024A (US06534493-20030318-C00166.png) 1969-07-25
AT292929B (de) 1971-09-10
GB1227992A (US06534493-20030318-C00166.png) 1971-04-15
DK120234B (da) 1971-05-03
SE339828B (US06534493-20030318-C00166.png) 1971-10-25
DE1903118A1 (de) 1969-08-07
NL162083C (nl) 1980-04-15
US3557162A (en) 1971-01-19
NL162083B (nl) 1979-11-15

Similar Documents

Publication Publication Date Title
ES362475A1 (es) Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides.
ES339689A1 (es) Procedimiento para la preparacion de 11 ibeta, 17 alfa-di- hidroxiesteroides.
ES408511A1 (es) Un procedimiento para la preparacion de compuestos polici- clicos.
AT311564B (de) Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen
CA793307A (en) 16-OXYGENATED-20-METHYL-.DELTA.17(20) PREGNEN-21-OIC ACIDS, 16-OXYGENATED-17.alpha.,20.alpha.-METHYLENE-21-OIC ACIDS OF THE PREGNANE SERIES, THEIR ESTERS, AND PROCESS FOR THEIR PREPARATION
GB1202254A (en) Process for removing proteins and decomposition products from waste water
CH551400A (de) Verfahren zur herstellung von 4-chlor-1, 2(alpha)-methylen(delta)4,6-pregnadien-17(alpha)-ol-3,20-dion bzw. dessen 17estern.
CH547789A (de) Verfahren zur herstellung von in 9,11(alpha)- und 12-stellung unsubstituierten 11(beta)-chlor- bzw. 11(beta)-brom-9(alpha)-steroiden.
ES358839A1 (es) Procedimiento de preparacion de 3 beta-hidroxi-delta5(10)- esteroides de la serie 10-nor-pregnano y estrano.
CA785276A (en) 17.alpha.-ALKYNYLESTRA-4,9(10)-DIENE-3.beta.,17.beta.-DIOLS, ESTERS THEREOF AND PROCESS THEREFOR
CA809206A (en) PROCESS FOR PREPARING 17.alpha.-ACYLOXY STEROIDS OF THE PREGNANE SERIES AND PRODUCTS THEREOF
CA781457A (en) 7.alpha.,17,17-TRIMETHYL-3-ENE STEROIDS OF THE ANDROSTANE AND 19-NORANDROSTANE SERIES AND PROCESS FOR THEIR PREPARATION
CA811721A (en) 17.alpha.-ALKA-1',3'-DIYNYL STEROIDS AND PROCESS FOR THEIR PREPARATION
CA740887A (en) 2-fluoro- and 6-fluoro-3-oxo-.delta.1,4-steroids of the androstane and pregnane series and process for the preparation thereof
CH429702A (de) Verfahren zur Herstellung von Thio- bzw. Dithiophosphor- (-phosphon-, phosphin-)säureestern
CA795780A (en) PROCESS FOR THE PREPARATION OF 9,11 HALIDES AND OXY GROUPINGS OF 17.alpha. ACYLOXY, 16 METHYL PREGNA .DELTA.1,4-DIENE, 3,20 DIONES
CA773110A (en) PROCESS FOR THE PREPARATION OF 17.alpha.-ACYLOXY-6-METHYL-16-METHYLENE-4,6-PREGNADIENE-3,20-DIONES
CA750363A (en) PROCESS FOR HYDROCYANATION OF 5.alpha.-FORMYL GROUP IN STEROIDS
CA733497A (en) PROCESS FOR THE PRODUCTION OF 17.alpha.-ALKYNYLANDROSTA-4,6-DIENE-3,17-DIOLS, ESTERS THEREOF AND CORRESPONDING 19-NOR COMPOUNDS
CA788448A (en) 6,16-DIMETHYL-17.alpha.-HYDROXY-.DELTA.4-3,20-DIOXO-STEROIDS OF THE PREGNANE SERIES AND PROCESS
CA779285A (en) 1,2.alpha.-METHYLENE STEROIDS OF THE PREGNANE SERIES AND PROCESS FOR THEIR MANUFACTURE
CA593343A (en) 9.alpha.-FLUORO HYDROCORTISONE 21-PHOSPHATE
CA596004A (en) 21-BROMO-3.beta.,17.alpha.-DIHYDROXY-11,20-DIKETO PREGNANE AND ALLOPREGNANE AND PREPARATION
ES317731A1 (es) Un metodo de producir 17-ceto, o 17-hidroxi-9 beta, 10 alfa-androstano
CH557341A (de) Verfahren zur herstellung von 18-methyl-9(beta), 10(alpha)-steroiden der androstanreihe.